Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
A10 Networks
ATEN
$1.93B
| $4.22M | ﹤0.01% |
975,409
+29,494
| +3% | +$135K |
|
|
VIRX
3077
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $4.21M | ﹤0.01% |
8,187
+513
| +7% | +$259K |
|
3078
Green Brick Partners
GRBK
$3.14B
| $4.2M | ﹤0.01% |
508,099
+4,177
| +0.8% | +$32.4K |
|
|
IFT
3079
DELISTED
IMPERIAL HLDGS INC COM STK (FL)
IFT
| $4.2M | ﹤0.01% |
601,852
+7,951
| +1% | +$52.1K |
|
|
MBVT
3080
DELISTED
Merchants Bancshares Inc
MBVT
| $4.19M | ﹤0.01% |
143,729
+1,253
| +0.9% | +$35.9K |
|
|
IVAC
3081
DELISTED
Intevac Inc
IVAC
| $4.19M | ﹤0.01% |
682,204
+1,025
| +0.2% | +$6.95K |
|
3082
Consumer Portfolio Services
CPSS
$206M
| $4.18M | ﹤0.01% |
598,633
+56,890
| +11% | +$381K |
|
3083
Assembly Biosciences
ASMB
$529M
| $4.16M | ﹤0.01% |
26,201
+15,650
| +148% | +$2.12M |
|
|
ENLC
3084
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $4.16M | ﹤0.01% |
127,726
+22,994
| +22% | +$762K |
|
|
DXYN
3085
DELISTED
Dixie Group Inc
DXYN
| $4.15M | ﹤0.01% |
458,910
+5,428
| +1% | +$47.6K |
|
|
AFH
3086
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
| $4.13M | ﹤0.01% |
233,746
+34,091
| +17% | +$589K |
|
|
BEBE
3087
DELISTED
Bebe Stores Inc
BEBE
| $4.13M | ﹤0.01% |
113,710
+2,075
| +2% | +$70.6K |
|
3088
NLI Holdings
NL
$317M
| $4.12M | ﹤0.01% |
532,185
+33,368
| +7% | +$250K |
|
|
XONE
3089
DELISTED
The ExOne Company
XONE
| $4.12M | ﹤0.01% |
301,823
+3,911
| +1% | +$58.3K |
|
|
RC
3090
Ready Capital
RC
$308M
| $4.11M | ﹤0.01% |
230,370
+8,391
| +4% | +$148K |
|
|
CSCD
3091
DELISTED
CASCADE MICROTECH, INC.
CSCD
| $4.09M | ﹤0.01% |
301,009
+7,681
| +3% | +$104K |
|
|
TAX
3092
DELISTED
Liberty Tax, Inc. Class A
TAX
| $4.08M | ﹤0.01% |
146,672
+19,838
| +16% | +$647K |
|
3093
Provident Financial
PROV
$112M
| $4.08M | ﹤0.01% |
254,855
+2,400
| +1% | +$37.6K |
|
3094
Inseego
INSG
$90.5M
| $4.07M | ﹤0.01% |
84,420
+9,999
| +13% | +$488K |
|
|
FXCB
3095
DELISTED
FOX CHASE BANCORP INC COM STK (MD)
FXCB
| $4.07M | ﹤0.01% |
241,687
+5,043
| +2% | +$83.3K |
|
|
GNMX
3096
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $4.06M | ﹤0.01% |
504,526
+71,219
| +16% | +$537K |
|
3097
Theriva Biologics
TOVX
$10.1M
| $4.06M | ﹤0.01% |
212
+54
| +34% | +$964K |
|
3098
Distribution Solutions Group
DSGR
$1.61B
| $4.06M | ﹤0.01% |
349,450
+1,600
| +0.5% | +$20.3K |
|
|
ORM
3099
DELISTED
Owens Realty Mortgage, Inc.
ORM
| $4.05M | ﹤0.01% |
270,574
+3,829
| +1% | +$53.1K |
|
3100
Microvision
MVIS
$78.9M
| $4.04M | ﹤0.01% |
78,606
+4,806
| +7% | +$173K |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.